Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 16 EP applications Scott Goodall has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11764947

RADIOPROTECTOR COMPOUNDS AND METHODS

IPC classification:
A61K 31/4184, A61P 39/00, A61P 43/00, C07D 235/18
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP12712748

METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE CONJUGATES

IPC classification:
A61K 39/00, A61K 47/48, C07K 9/00
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut Pasteur
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14162956

Cysteine protease inhibitors

IPC classification:
A61K 31/16, A61P 11/00, A61P 37/00, C07C 237/14, C07D 233/58
Agent:
Scott Goodall, Sagittarius IP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13716919

USE OF NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY

IPC classification:
A61K 38/16, A61K 38/17, A61K 38/18, A61P 25/02
Agent:
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP13830653

PERFORIN INHIBITING BENZENESULFONAMIDE COMPOUNDS, PREPARATION AND USES THEREOF

IPC classification:
A61K 31/4035, A61K 31/404, A61K 31/4439, A61K 31/444, A61K 31/5377, A61P 3/10, A61P 37/06, C07D 401/10, C07D 409/10, C07D 409/14, C07D 417/14
Agent:
Scott Goodall, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14712964

THERAPEUTIC DOSING OF A NEUREGULIN OR A FRAGMENT THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE

IPC classification:
A61K 38/18, A61P 9/00
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14750516

FORM 2 CRYSTALLINE POLYMORPH OF A SALT OF N-[1-6-(ETHYNYL-3-OXO-HEXAHYDRO-FURO[3,2-B]PYRROLE-4-CARBONYL)-3-METHYL-BUTYL]-4-[5-FLUORO-2-(4-METHYL-PIPERAZINYL)THIAZOL-4-YL]-BENZAMIDE USEFUL AS CYSTEINE PROTEASE INHIBITOR

IPC classification:
A61K 31/496, A61P 19/00, C07D 491/048
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP14789434

HCV POLYMERASE INHIBITORS

IPC classification:
A61P 31/14, C07H 19/06, C07H 19/16
Agent:
Scott Goodall, Sagittarius IP
Status:
The patent has been granted
EP12185376

Insulinotropic peptide derivative wherein its n-terminal amino acid is modified

IPC classification:
C07K 14/00, C07K 14/65
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12185370

Insulinotropic peptide derivative wherein its N-terminal amino acid is modified

IPC classification:
C07K 14/00, C07K 14/65
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14802498

HCV POLYMERASE INHIBITORS

IPC classification:
A61K 31/7068, A61K 31/7072, A61P 31/14, C07H 19/06, C07H 19/10
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION IN PROGRESS
EP11805571

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

IPC classification:
A61K 31/4178, A61K 31/4439, A61K 31/506, A61P 25/08, A61P 25/18, A61P 27/16, A61P 43/00, C07D 405/12, C07D 413/12, C07D 413/14
Agent:
Scott Goodall, Sagittarius IP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11794778

MYCOBACTERIUM ANTIGENIC COMPOSITION

IPC classification:
A61K 39/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15756888

DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/506, A61P 35/00, C07D 405/04, C07F 9/24
Agent:
Scott Goodall, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP15763562

METHODS FOR THE PREPARATION OF DIASTEREOMERICALLY PURE PHOSPHORAMIDATE PRODRUGS

IPC classification:
C07H 1/04, C07H 19/10, C07H 19/20
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made
EP17176973

HCV POLYMERASE INHIBITORS

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/073, C07H 19/10, C07H 19/16, C07H 19/173
Agent:
Scott Goodall, Sagittarius IP
Status:
Request for examination was made

Please Sign in to use this feature